Current participation in another therapeutic clinical trial
Current treatment or participation on another therapeutic clinical trial
Current treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial
Concurrent enrollment in another therapeutic clinical trial.
Current participation in another clinical trial of a drug or device or past participation within 4 weeks before Baseline or subject is in exclusion period from a previous clinical trial
Concurrent participation in another therapeutic clinical trial.
Is participating in another therapeutic clinical trial
Enrollment into another therapeutic clinical trial.
Concurrent participation in another therapeutic or imaging clinical trial.
Concurrent participation in another therapeutic treatment trial
Current treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial.
Simultaneous participation in other therapeutic clinical trials will not be allowed
CAPMATINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial
CERITINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial
REGORAFENIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial
ENTRECTINIB EXCLUSION CRITERIA: Current participation in another therapeutic clinical trial
Simultaneous participation in other therapeutic clinical trials will be allowed
Current treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial
Concurrent treatment with any other anti-neoplastic drug or concurrent participation in another therapeutic clinical trial
Concurrent treatment with any other anti-neoplastic drug or concurrent participation in another therapeutic clinical trial
Current treatment on another clinical trial; participation in non-therapeutic clinical trials is permissible
Participation in another clinical trial within 4 weeks
Current treatment on another therapeutic clinical trial
Current participation in another therapeutic clinical trial.
Major surgical intervention or participation in a therapeutic clinical trial within 28 days from Day 1 of the first dose of MSC2363318A
Current treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial.
Participation in any other clinical trial
Treatment on another therapeutic clinical trial within 4 weeks of enrollment in this trial
Simultaneous participation in other therapeutic clinical trials will not be allowed
Current treatment on another therapeutic clinical trial
concurrent treatment on another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial
Concurrent participation in another therapeutic clinical trial;
Concurrent participation in another therapeutic clinical trial
Received last dose of study drug on another therapeutic clinical trial within 30 days prior to randomization
Current treatment on another therapeutic clinical trial
Current participation in another drug trial
Received last dose of study drug on another therapeutic clinical trial within 30 days prior to enrollment
Participation in a therapeutic research trial within the past three months
Actively participating in another therapeutic clinical trial
Simultaneous participation in other therapeutic clinical trials will not be allowed
Concurrent participation in another therapeutic treatment trial.
Concurrent participation in another therapeutic clinical trial.
Participation in a therapeutic clinical trial
Concurrent participation in another clinical trial
Current enrollment in a therapeutic clinical trial
Current treatment on another therapeutic clinical trial